{"id":"clonidine-pill","safety":{"commonSideEffects":[{"rate":"40","effect":"Dry mouth"},{"rate":"33","effect":"Drowsiness"},{"rate":"16","effect":"Dizziness"},{"rate":"10","effect":"Constipation"},{"rate":"10","effect":"Sedation"},{"rate":"null","effect":"Headache"},{"rate":"null","effect":"Rebound hypertension (upon discontinuation)"}]},"_chembl":{"chemblId":"CHEMBL1705","moleculeType":"Small molecule","molecularWeight":"266.56"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Clonidine binds to alpha-2 adrenergic receptors in the central nervous system, particularly in the locus coeruleus, which decreases the release of norepinephrine and reduces overall sympathetic outflow. This leads to decreased heart rate, blood pressure, and peripheral vascular resistance. The drug also has peripheral alpha-2 agonist effects that contribute to its antihypertensive action.","oneSentence":"Clonidine is an alpha-2 adrenergic agonist that reduces sympathetic nervous system activity by stimulating alpha-2 receptors in the brain and periphery.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:30:18.940Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Attention-deficit/hyperactivity disorder (ADHD)"},{"name":"Opioid withdrawal"},{"name":"Menopausal hot flashes"}]},"trialDetails":[{"nctId":"NCT00262470","phase":"PHASE1, PHASE2","title":"Treatment of Orthostatic Intolerance","status":"ACTIVE_NOT_RECRUITING","sponsor":"Satish R. Raj","startDate":"1997-04","conditions":"Tachycardia, Chronic Orthostatic Intolerance","enrollment":150},{"nctId":"NCT04877093","phase":"PHASE3","title":"Repurposing Low-Dose Clonidine for PTSD in Veterans","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2023-06-01","conditions":"PTSD, Posttraumatic Stress Disorder, Sleep","enrollment":32},{"nctId":"NCT04934228","phase":"PHASE1","title":"Mitigating the Pro-inflammatory Phenotype of Obesity","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2021-07-01","conditions":"Blood Pressure, Diabetes, Obesity","enrollment":60},{"nctId":"NCT03109795","phase":"PHASE4","title":"Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System","status":"TERMINATED","sponsor":"University of Iowa","startDate":"2017-04-10","conditions":"Anxiety, Hypertension","enrollment":35},{"nctId":"NCT03537612","phase":"PHASE3","title":"Sensorial and Physiological Mechanism-based Assessments of Perioperative Pain","status":"TERMINATED","sponsor":"Dr. Jean A. Ouellet, MD, FRCSC","startDate":"2018-06-22","conditions":"Scoliosis","enrollment":15},{"nctId":"NCT05318248","phase":"NA","title":"The Role of Stress Neuromodulators in Decision Making Under Risk (Part II)","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2022-03-01","conditions":"Stress","enrollment":82},{"nctId":"NCT05277038","phase":"","title":"Clonidine is Better Than Zopiclone for Insomnia Treatment in Chronic Pain Patients","status":"COMPLETED","sponsor":"Salem Anaesthesia Pain Clinic","startDate":"2022-03-01","conditions":"Insomnia Chronic, Pain, Chronic","enrollment":150},{"nctId":"NCT04032691","phase":"EARLY_PHASE1","title":"PET Study of a2a Agonist Effects on the Ventricular CSF Clearance of [11C]Butanol","status":"WITHDRAWN","sponsor":"Weill Medical College of Cornell University","startDate":"2019-08-27","conditions":"Healthy Volunteers","enrollment":""},{"nctId":"NCT04030572","phase":"EARLY_PHASE1","title":"Feasibility of Administering Clonidine as a Pharmacological Challenge in Imaging Studies","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2019-12-10","conditions":"Neuro-Degenerative Disease, Cancer","enrollment":3},{"nctId":"NCT01956604","phase":"PHASE2","title":"The Oslo Study of Clonidine in Elderly Patients With Delirium","status":"TERMINATED","sponsor":"Oslo University Hospital","startDate":"2014-04-10","conditions":"Delirium","enrollment":20},{"nctId":"NCT00223717","phase":"PHASE1","title":"Treatment of Supine Hypertension in Autonomic Failure","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2001-01","conditions":"Hypertension","enrollment":152},{"nctId":"NCT02812368","phase":"PHASE2","title":"Clonidine for Sleep Disturbances in Children With Autism Spectrum Disorder","status":"WITHDRAWN","sponsor":"Ohio State University","startDate":"2016-08","conditions":"Autism Spectrum Disorder","enrollment":""},{"nctId":"NCT01112878","phase":"PHASE4","title":"Oral Clonidine & Gabapentin: Improving Recovery and Pain Management After Outpatient With Major Orthopedic Surgery","status":"WITHDRAWN","sponsor":"Cedars-Sinai Medical Center","startDate":"2015-06","conditions":"Shoulder Arthroscopy, Knee Arthroscopy","enrollment":""},{"nctId":"NCT00884832","phase":"PHASE2","title":"A Placebo-Controlled Study of Clonidine for Fecal Incontinence.","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2008-10","conditions":"Fecal Incontinence","enrollment":44},{"nctId":"NCT01784250","phase":"PHASE2","title":"Efficacy of Clonidine and Propranolol in Dentistry (AAA)","status":"UNKNOWN","sponsor":"CES University","startDate":"2012-08","conditions":"Anxiety","enrollment":60}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"APPLICATION SITE ERYTHEMA"},{"count":1,"reaction":"APPLICATION SITE PRURITUS"},{"count":1,"reaction":"APPLICATION SITE RASH"},{"count":1,"reaction":"BLOOD PRESSURE INCREASED"},{"count":1,"reaction":"FATIGUE"},{"count":1,"reaction":"POLLAKIURIA"},{"count":1,"reaction":"SLEEP DISORDER"},{"count":1,"reaction":"URTICARIA"}],"_approvalHistory":[],"publicationCount":16,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["On-Drug","Clonidine"],"phase":"marketed","status":"active","brandName":"Clonidine Pill","genericName":"Clonidine Pill","companyName":"Weill Medical College of Cornell University","companyId":"weill-medical-college-of-cornell-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Clonidine is an alpha-2 adrenergic agonist that reduces sympathetic nervous system activity by stimulating alpha-2 receptors in the brain and periphery. Used for Hypertension, Attention-deficit/hyperactivity disorder (ADHD), Opioid withdrawal.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":5,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}